Home » Topics » Regulatory

Regulatory
RSS

MicardisPlus approved in E.U. for hypertension

May 28, 2002

New indication and low dose strength of Vivelle-Dot approved

May 27, 2002

Copaxone prefilled syringes launched in Canada

May 27, 2002

MitoExtra NDA amendment accepted for filing

May 27, 2002

New strengths of Adderall XR approved for ADHD

May 27, 2002

Zelapar NDA in Parkinson's disease accepted for filing

May 27, 2002

Remodulin approved for pulmonary arterial hypertension

May 24, 2002

FDA advisory committee supports efficacy of Prevnar in otitis media

May 23, 2002

Low-dose formulation of Retin-A Micro approved by FDA

May 23, 2002

FDA approves Zoloft for premenstrual dysphoric disorder

May 22, 2002

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...